Standfirst

A life and pensions consolidator, a London flexible-office landlord fighting an activist campaign, and a care-home REIT are grouped here under an "income and real estate" banner. Only two of the three are genuine property businesses; Chesnara plc (LSE:CSN) is an insurance consolidator whose relevance is its dividend, not its buildings. This review sets out each company’s latest verified results and the risks behind the yields.

Introduction – Sector Outlook for September 2026

UK income and property stocks are navigating a monetary backdrop that has stopped tightening without yet easing. The Bank of England held its Base Rate at 3.75% on 30 July 2026, with the Monetary Policy Committee split 6–3 as three members pushed for a rise to 4% amid firmer inflation; UK CPI rose to 2.9% in July 2026, up from 2.6% in June, and the Bank was widely expected to hold again at its 17 September 2026 meeting. Higher-for-longer borrowing costs matter differently to each of the three companies here: they affect the discount rate applied to real estate valuations and pension liabilities, the cost of Debt used to fund acquisitions and refurbishment, and the Solvency and Dividend capacity of an insurance consolidator running long-dated policyholder books.

Only two of the three are genuine real estate businesses. Workspace Group is a London-focused flexible-office landlord letting studios and managed space to small and mid-sized businesses across 57 locations, while Target Healthcare REIT owns purpose-built care homes let on very long leases to specialist operators. Chesnara is neither a landlord nor an operator of property; it is a consolidator of closed and open life and pensions books across the UK, Sweden and the Netherlands, generating cash from in-force policies rather than rental income. Its inclusion in this grouping reflects only that its dividend Yield and defensive cash generation sit alongside the two REITs’ income profiles, and this article treats it accordingly, as an insurance consolidator rather than a property company.

Conditions differ by segment. UK care-home real estate has continued to attract institutional Capital on the back of structural Demand from an ageing population, evidenced by Target Healthcare’s continued net asset value growth through 2026. London flexible office space, by contrast, has faced a harder 2026: Workspace reported falling rent roll and a swing to a statutory loss reflecting property devaluation, while also contesting a Shareholder requisition from an activist investor. Life and pensions consolidation has been reshaped by continued back-book M&A, with Chesnara’s February 2026 completion of the HSBC Life (UK) Acquisition a case in point.

The company-by-company analysis that follows examines Chesnara, Workspace and Target Healthcare REIT in turn, before a period-labelled comparison, the catalysts most likely to matter into year-end and a balanced assessment of the risks.

Chesnara Plc (LSE:CSN)

Chesnara is a life and pensions consolidator, not a real estate company, despite its place in this income-themed grouping. Formed on the London Stock Exchange in 2004, it acquires and manages closed and open books of Life insurance and pensions policies, generating cash from existing policyholders rather than new Underwriting growth or property rents. Its subsidiaries span Countrywide Assured (UK), Movestic (Sweden) and The Waard Group and Scildon (Netherlands), covering roughly 1.3 million policyholders. On 2 February 2026 Chesnara completed the acquisition of HSBC Life (UK) Limited, subsequently rebranded Chesnara Life UK, adding an estimated £5 billion of Assets under administration and more than 440,000 policies; pro forma group assets under administration reached approximately £21 billion — £11 billion UK, £7 billion Sweden and £3 billion Netherlands — at 30 June 2026.

In half-year results for HY2026 (six months to 30 June 2026), Chesnara reported adjusted operating profit of £31 million, up 46% on £21 million in HY2025, and operating capital generation of £96 million, up 79% from £54 million, with cash remittances to the centre of £73 million against £56 million a year earlier. Own funds rose 14% to £976 million. Under IFRS 17, the contractual service Margin — the store of future profit still to be recognised — stood at £327 million net of tax at 30 June 2026, up £196 million from £131 million at FY2025, an increase management attributed mainly to the Chesnara Life UK acquisition, with new Business contribution of £12 million (up 152% year on year, split £7 million UK, £2 million Sweden and £3 million Netherlands) and interest accretion also contributing.

The Solvency II coverage ratio was 185% at 30 June 2026, above the group’s 140%–160% target operating range and above the approximately 180% pro forma level flagged when the HSBC Life UK deal was announced, though down from a standalone 257% at FY2025 before the acquisition consumed capital. The board increased the Interim Dividend by 6% to 8.16 pence per share, continuing a 21-year track record of dividend growth. Management has guided the HSBC Life UK transaction to generate over £800 million of lifetime cash generation and over £140 million over five years, targets not yet tested against a full year of combined trading.

Market data as at 14 September 2026 show the shares at 354.5p, valuing the group at approximately £820.1 million. The trailing P/E of about 824 times reflects statutory IFRS EPS of only 0.43 pence over the Trailing Twelve Months — an artefact of insurers absorbing one-off acquisition costs — rather than a conventional multiple, and should not be read against the adjusted operating profit above without that context. The Dividend Yield stands at 6.35%; the supplied dataset records a consensus rating of Buy.

Catalysts include integration of Chesnara Life UK, further bolt-on acquisitions consistent with the group’s 15-deal history since 2004, and full-year 2026 results expected around March 2027. Risks include solvency sensitivity to interest-rate and equity-market movements, integration risk on a transaction that materially increased the UK book, and the complexity of running with-profits and unit-linked business across three regulatory jurisdictions.

Workspace Group PLC (LSE:WKP)

Workspace Group is a London-focused real estate Investment trust providing flexible and managed office space, operating 57 locations totalling roughly 3.8 million square feet let mainly to small and medium-sized businesses. Unlike a conventional long-lease office landlord, its income depends on occupancy and per-square-foot pricing across flexible licences, closer in operation to a serviced-space operator than to a typical REIT with multi-year, fixed-rent tenancies.

In full-year results for FY2025/26 (year to 31 March 2026), published 10 June 2026, Workspace reported net rental income of £113.4 million, down 7.1% from £122.1 million; total rental income fell to £134.3 million from £138.2 million. Total rent roll declined 8.6% to £127.3 million, though stabilised-portfolio rent roll fell a smaller 4.6% to £108.3 million. Overall occupancy improved to 79.4% from 78.5%, while stabilised-portfolio occupancy eased to 81.6% from 83.0%. Trading profit after interest fell 9.4% to £60.5 million, and the group swung to a statutory loss before tax of £120.5 million, from a profit of £5.4 million in FY2025, driven by property Revaluation losses rather than trading performance. EPRA Earnings Per Share fell to 31.5 pence from 34.8 pence, and adjusted underlying EPS fell 9.3% to 31.3 pence.

EPRA net tangible assets per share fell 11.2% to approximately 686.9 pence, from 774 pence a year earlier, reflecting the devaluation. Net debt reduced to £758 million from £820 million, though loan-to-value rose slightly to 35% from 34%; undrawn facilities and cash totalled £242 million. The board recommended a final dividend of 16.7 pence, taking the total FY2026 dividend to 26.1 pence, down from 28.4 pence in FY2025. New Leadership took over during the year: Charlie Green, co-founder of The Office Group, became chief executive in February 2026, and Tom Edwards-Moss, previously chief executive of Hibernia REIT, became chief financial officer the same month, launching a "Fix, Accelerate, Scale" strategy targeting over £125 million of organic trading profit before interest medium-term, alongside a £200 million disposal target by FY2027.

The year has also been dominated by a contested shareholder campaign. Saba Capital, disclosed as holding approximately 27% economic interest, requisitioned Workspace’s 2026 AGM and nominated six directors to replace the board’s independent non-executives, pushing for large-scale asset disposals; the board unanimously recommended shareholders vote for its own resolutions and against Saba’s nominees ahead of the AGM held on 23 July 2026. Workspace noted in its own materials that its share price was down around 50% over one year and that the shares traded at a 19% discount to net tangible assets against a stated peer average of around 8%. Market data as at 14 September 2026 show the shares at 360p, valuing the group at approximately £693.4 million; the trailing P/E is not meaningful given the FY2026 statutory loss (trailing EPS of approximately –62.6 pence), and the dividend yield is 7.25% on the FY2026 total payout; the supplied dataset records a consensus rating of Buy.

Catalysts include progress against the £200 million FY2027 disposal target, delivery of the refurbishment and repricing programme under new management, and the ongoing resolution of the Saba Capital situation following the July 2026 AGM. Principal risks are a further decline in London flexible-office demand or pricing, continued property Devaluation pressuring loan-to-value headroom, and the governance uncertainty and cost associated with an unresolved activist campaign holding a large economic stake.

Target Healthcare REIT PLC (LSE:THRL)

Target Healthcare REIT describes itself as the UK’s first care-home REIT, investing exclusively in modern, purpose-built care homes with features such as en-suite wet rooms, let on long leases to specialist operators. Its income derives entirely from contracted rent rather than operating care services itself, giving it exposure to long-term care demand and operator solvency rather than the property cycle affecting offices or retail.

In interim results for HY2026 (six months to 31 December 2025, reflecting the trust’s 30 June year-end), Target Healthcare reported total Revenue of £36.9 million, up from £35.3 million, and EPRA earnings per share of 4.22 pence, up from 3.94 pence; the group’s specific adjusted EPRA EPS measure rose 8.5% to 3.40 pence from 3.13 pence. IFRS profit rose 57% to £47.0 million from £30.0 million, reflecting valuation gains alongside operating income. The board declared a dividend of 3.016 pence for the period, up 2.5% from 2.942 pence. EPRA net tangible assets per share rose to 119.4 pence from 114.8 pence at 30 June 2025, with EPRA net disposal value per share of 123.5 pence.

The portfolio was valued at £895 million across 86 homes and 5,885 beds at the December 2025 period end, with portfolio-level occupancy of 100%, mature-home occupancy of 86%, and a weighted average unexpired Lease term of 26.3 years, among the longest in UK listed real estate. Contracted annual rent stood at £59.5 million, and net loan-to-value was a conservative 15.2%. A subsequent Quarterly Report as at 30 June 2026 (5 August 2026) showed further progress: EPRA NTA per share of 122.1 pence, portfolio value of £924.1 million, net debt of £149.1 million, net loan-to-value of 16.1%, a quarterly dividend of 1.508 pence, and rent collection of 100% following disposal of a previously non-paying tenant’s asset.

Market data as at 14 September 2026 show the shares at 110p, valuing the group at approximately £682.3 million, on a trailing price-to-earnings multiple of about 8.8 times trailing-twelve-month earnings per share of 12.56 pence, and a dividend yield of 5.48%; the supplied dataset records a consensus rating of Buy. Both Leverage and dividend cover compare favourably with several other listed UK REITs.

Catalysts include continued NAV and rent-roll growth as homes mature toward target occupancy, further quarterly NAV updates due at the trust’s usual November, February, May and August intervals, and full-year results expected around September 2026 covering the year to 30 June 2026. Principal risks are mature-home occupancy still below the portfolio-level 100% headline figure, tenant concentration among a limited number of specialist care operators, and sensitivity to UK long-term-care funding policy and staffing costs across the operator base, even though the REIT itself does not run the homes.

How the Three FTSE All-Share Stocks Compare

Read together, the grouping shows how loosely an "income and real estate" label can be applied. Target Healthcare stands out for conservative leverage, long lease terms and steady NAV growth; Workspace offers the highest nominal yield of the three but carries a statutory loss, falling NTA and an unresolved activist situation; Chesnara’s extreme trailing P/E is a reporting artefact of insurer accounting following a transformative acquisition, and its relevance to income investors rests on cash generation and solvency headroom rather than any conventional earnings multiple.

What Could Drive the Income and Real Estate Sector Through the Rest of 2026?

For Target Healthcare, the dominant driver remains structural demand for modern care-home beds against an ageing UK population, combined with the trust’s ability to keep mature-home occupancy moving toward its portfolio-level 100% figure. Its long, largely inflation-linked leases and conservative 15–16% net loan-to-value leave it comparatively insulated from short-term rate moves, though not from the underlying financial health of its care-operator tenants.

For Workspace, the key questions are whether new management’s "Fix, Accelerate, Scale" strategy can restore rent-roll growth, whether the £200 million FY2027 disposal programme completes on acceptable terms, and how the contest with Saba Capital resolves following the July 2026 AGM.

For Chesnara, the relevant driver is not property demand but the pace of UK, Swedish and Dutch life and pensions consolidation, and its ability to integrate the enlarged UK book from HSBC Life without repeating the one-off costs that depressed statutory EPS in the completion year. Continued M&A, funded from solvency headroom above target, is a plausible driver of further growth.

Potential Catalysts to Watch

Target Healthcare is due to report full-year results to 30 June 2026 around September 2026, with its next quarterly NAV update following the usual November cadence. Workspace’s next scheduled disclosure is a first-half FY2027 business update, likely October or November 2026, providing the first read on progress against the £200 million disposal target and occupancy trends following the AGM. Chesnara is not due to report full-year 2026 results until around March 2027, but further M&A, consistent with its acquisitive history, could arrive at any point. The Bank of England’s 17 September 2026 rate decision is a shared near-term event for all three.

Key Risks Investors Should Consider

Chesnara’s principal risks are Solvency II sensitivity to interest-rate and equity-market movements affecting assets backing its long-dated liabilities, integration risk following the HSBC Life UK acquisition, and the complexity of running with-profits and unit-linked business across three regulatory regimes. Its 21-year dividend growth record does not guarantee continuation if capital generation were to come under pressure.

Workspace’s risks are centred on continued softness in London flexible-office demand and pricing, further property devaluation pressuring its 35% loan-to-value, and the unresolved contest with Saba Capital, which could bring board changes or continued governance distraction regardless of outcome. A share price already down around 50% over one year reflects some of this being priced in, but does not eliminate execution risk under new management.

Target Healthcare’s risks are more modest: mature-home occupancy of 86% leaves room for disappointment if newer homes stabilise more slowly than expected, and tenant concentration among a limited number of specialist care operators exposes the trust to any single operator’s financial difficulty. Across all three companies, a sharper UK slowdown or a delayed start to Bank of England rate cuts would raise financing costs and discount rates in ways that could affect valuations, solvency ratios and dividend cover alike, even though the transmission mechanism differs for an insurer, an office landlord and a care-home REIT.

Conclusion

Chesnara, Workspace Group and Target Healthcare REIT illustrate how differently three FTSE All-Share "income" stocks can be constructed. Chesnara generates cash from consolidating life and pensions books rather than property; Target Healthcare owns long-leased, purpose-built care homes with conservative leverage and steady NAV growth; Workspace is a flexible-office landlord working through a valuation-driven loss and a live activist campaign.

Each has reported genuine progress on at least one measure in 2026 — operating capital generation and dividend growth at Chesnara, NAV and rent-collection improvement at Target Healthcare, and occupancy gains alongside a new strategic plan at Workspace — while each carries risks distinct to its own model. Investors should treat this grouping as three separate businesses with three separate risk profiles, connected only by shared exposure to UK interest rates and their appearance in the FTSE All-Share.